{
  "abstract": "Itai Bavli and colleagues argue that the growing use of AI by commercial industries is creating new opportunities to influence health, and an AI commercial determinants of health framework may help to identify and assess emerging mechanisms of influence",
  "authors": [
    {
      "affiliations": [
        "Department of Science, Technology and Society, Interdisciplinary Studies, Bar-Ilan University, Israel",
        "School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada"
      ],
      "name": "Itai Bavli"
    },
    {
      "affiliations": [
        "School of Health Policy and Management, York University, Toronto, ON, Canada"
      ],
      "name": "Joel Lexchin"
    },
    {
      "affiliations": [
        "School of Public Health, Washington University, MO, USA"
      ],
      "name": "Sandro Galea"
    },
    {
      "affiliations": [
        "Department of Equity, Ethics and Policy, School of Population and Global Health, McGill University, QC, Canada"
      ],
      "name": "Nicholas King"
    },
    {
      "affiliations": [
        "Department of Science, Technology and Society, Interdisciplinary Studies, Bar-Ilan University, Israel"
      ],
      "name": "Nadav Davidovitc"
    }
  ],
  "title": "Artificial intelligence as a new commercial determinant of health",
  "uid": "e162f3b3-5348-59d5-acf5-11e5e8d0b415"
}